These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3219572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR.
    Brain Res; 1982 Feb 18; 234(1):123-36. PubMed ID: 7059818
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
    Kurata K, Shibata R.
    Pharmacology; 1991 Feb 18; 42(1):1-9. PubMed ID: 2057516
    [Abstract] [Full Text] [Related]

  • 5. Opiate actions on mesocortical dopamine metabolism in the rat.
    Kim HS, Iyengar S, Wood PL.
    Life Sci; 1986 Nov 24; 39(21):2033-6. PubMed ID: 3784768
    [Abstract] [Full Text] [Related]

  • 6. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J, Meltzer HY.
    Brain Res; 1992 Mar 06; 574(1-2):98-104. PubMed ID: 1379112
    [Abstract] [Full Text] [Related]

  • 7. Effect of cholecystokinin on acetylcholine turnover and dopamine release in the rat striatum and cortex.
    Cosi C, Altar AC, Wood PL.
    Eur J Pharmacol; 1989 Jun 20; 165(2-3):209-14. PubMed ID: 2776829
    [Abstract] [Full Text] [Related]

  • 8. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
    Altar CA, Boyar WC.
    Brain Res; 1989 Apr 03; 483(2):321-6. PubMed ID: 2706523
    [Abstract] [Full Text] [Related]

  • 9. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat.
    Wiesel FA, Sedvall G.
    Eur J Pharmacol; 1975 Feb 03; 30(2):364-7. PubMed ID: 236193
    [Abstract] [Full Text] [Related]

  • 10. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL, Szabó G, Penke B, Telegdy G.
    Eur J Pharmacol; 1981 Jan 29; 69(3):313-9. PubMed ID: 6260512
    [Abstract] [Full Text] [Related]

  • 11. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S, Watson E, Stanley ME.
    J Pharmacol Exp Ther; 1975 Nov 29; 195(2):265-70. PubMed ID: 1185596
    [Abstract] [Full Text] [Related]

  • 12. On the origin of striatal cholecystokinin release: studies with in vivo microdialysis.
    You ZB, Herrera-Marschitz M, Brodin E, Meana JJ, Morino P, Hökfelt T, Silveira R, Goiny M, Ungerstedt U.
    J Neurochem; 1994 Jan 29; 62(1):76-85. PubMed ID: 7903356
    [Abstract] [Full Text] [Related]

  • 13. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ, Bunney EB, Roth RH.
    Brain Res; 1981 Aug 10; 218(1-2):376-82. PubMed ID: 7272743
    [Abstract] [Full Text] [Related]

  • 14. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 10; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 15. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB, Strupish J, Nahorski SR.
    Brain Res; 1986 Apr 09; 370(2):310-4. PubMed ID: 3708329
    [Abstract] [Full Text] [Related]

  • 16. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY, Zhang Y, Stockmeier CA.
    Eur J Pharmacol; 1992 May 27; 216(1):67-71. PubMed ID: 1388121
    [Abstract] [Full Text] [Related]

  • 17. Bilateral neurochemical changes induced by unilateral cerebral haloperidol administration: evidence for cerebral asymmetry in the rat.
    Hyde JF, Jerussi TP.
    Pharmacol Biochem Behav; 1992 Jul 27; 42(3):457-64. PubMed ID: 1409779
    [Abstract] [Full Text] [Related]

  • 18. Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.
    Tanganelli S, Fuxe K, von Euler G, Eneroth P, Agnati LF, Ungerstedt U.
    J Neural Transm Gen Sect; 1990 Jul 27; 81(3):183-94. PubMed ID: 2397084
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.